[SCHEDULE 13D/A] STAAR SURGICAL CO SEC Filing
Broadwood group reports a 27.4% stake in STAAR Surgical (STAA) and is actively opposing the proposed merger with Alcon. The Reporting Persons—Broadwood Partners, Broadwood Capital and individuals including Neal C. Bradsher—may be deemed to beneficially own 13,519,491 shares out of 49,354,123 outstanding (approximately 27.4%). On September 15, 2025 they filed a preliminary proxy statement and a GREEN Proxy Card to solicit proxies to oppose approval of the Merger Agreement and a related non-binding compensation proposal at a special meeting scheduled for October 23, 2025. The Reporting Persons executed a Joint Filing and Solicitation Agreement on September 17, 2025 to coordinate filings and proxy solicitation; Broadwood Partners will bear pre-approved expenses. The filing discloses Mr. LeBuhn purchased 21,286 shares for approximately $135,888.02 from personal funds and that no Reporting Person transacted in the past 60 days.
Il gruppo Broadwood segnala una partecipazione del 27,4% in STAAR Surgical (STAA) e si oppone attivamente alla fusione proposta con Alcon. I Reporting Persons—Broadwood Partners, Broadwood Capital e individui tra cui Neal C. Bradsher—potrebbero essere considerati titolari beneficiari di 13.519.491 azioni su un totale di 49.354.123 in circolazione (circa il 27,4%). Il 15 settembre 2025 hanno presentato una bozza preliminare di procura e una GREEN Proxy Card per richiedere deleghe al fine di opporsi all’approvazione dell’Merger Agreement e a una proposta di compensazione non vincolante correlata, in occasione di una riunione speciale prevista per il 23 ottobre 2025. I Reporting Persons hanno stipulato un Joint Filing and Solicitation Agreement il 17 settembre 2025 per coordinare nomine e sollecitazione delle deleghe; Broadwood Partners si farà carico delle spese pre-approvate. Il fascicolo indica che il signor LeBuhn ha acquistato 21.286 azioni per circa 135.888,02 dollari con fondi personali e che nessun Reporting Person ha effettuato operazioni negli ultimi 60 giorni.
El grupo Broadwood informa una participación del 27,4% en STAAR Surgical (STAA) y se opone activamente a la fusión propuesta con Alcon. Las Personas que Informan—Broadwood Partners, Broadwood Capital y particulares, incluido Neal C. Bradsher—podrían considerarse propietarios beneficiarios de 13.519.491 acciones de un total de 49.354.123 en circulación (aproximadamente el 27,4%). El 15 de septiembre de 2025 presentaron una declaración preliminar de poder y una Green Proxy Card para solicitar delegaciones con el fin de oponerse a la aprobación del Acuerdo de Fusión y a una propuesta de compensación no vinculante relacionada, en una reunión especial programada para el 23 de octubre de 2025. Las Personas que Informan firmaron un Acuerdo conjunto de Presentación y Solicitud de poder el 17 de septiembre de 2025 para coordinar presentaciones y la solicitud de poderes; Broadwood Partners asumirá gastos preaprobados. El expediente indica que el señor LeBuhn compró 21.286 acciones por aproximadamente $135.888,02 con fondos personales y que ninguna Persona Informante ha operado en los últimos 60 días.
브로드우드 그룹은 STAAR Surgical(STAA)에 27.4%의 지분을 보유하고 있으며 Alcon과의 제안된 합병에 적극적으로 반대하고 있습니다. 보고인들—Broadwood Partners, Broadwood Capital 및 Neal C. Bradsher를 포함한 개인들—은 발행 주식 총수 49,354,123주 중 13,519,491주를 유익하게 소유할 수 있다고 간주될 수 있습니다(약 27.4%). 2025년 9월 15일 예비 위임장 및 GREEN Proxy Card를 제출하여 2025년 10월 23일로 예정된 특별 주주총회에서 합병계약 승인에 반대하고 관련 비구속적 보상 제안에 반대하기 위한 위임장을 모으려 했습니다. 보고인들은 2025년 9월 17일에 서류 제출 및 위임 모집을 조정하는 공동 제출 및 위임 모집 계약(Joint Filing and Solicitation Agreement)을 체결했습니다; Broadwood Partners는 사전 승인된 비용을 부담할 것입니다. 제출서는 LeBuhn 씨가 개인 자금으로 약 135,888.02달러에 21,286주를 매수했고, 지난 60일 동안 어떤 보고인도 거래를 하지 않았다고 밝힙니다.
Le groupe Broadwood indique une participation de 27,4 % dans STAAR Surgical (STAA) et s’oppose activement à la fusion proposée avec Alcon. Les personnes détenant l’information—Broadwood Partners, Broadwood Capital et des particuliers dont Neal C. Bradsher—pourraient être considérées comme détenant des actions bénéficiaires à hauteur de 13 519 491 sur un total de 49 354 123 actions en circulation (environ 27,4 %). Le 15 septembre 2025, ils ont déposé une déclaration préliminaire et une GREEN Proxy Card pour solliciter des procurations afin de s’opposer à l’approbation du Merger Agreement et à une proposition de rémunération non contraignante associée, lors d’une assemblée spéciale prévue le 23 octobre 2025. Les personnes détenant l’information ont signé un accord conjoint de dépôt et de sollicitation le 17 septembre 2025 pour coordonner les dépôts et la sollicitation de procurations; Broadwood Partners assumera les dépenses préapprouvées. Le dossier révèle que M. LeBuhn a acheté 21 286 actions pour environ 135 888,02 $ avec des fonds personnels et qu’aucune des personnes détenant l’information n’a effectué de transactions au cours des 60 derniers jours.
Die Broadwood-Gruppe meldet eine Beteiligung von 27,4 % an STAAR Surgical (STAA) und lehnt die vorgeschlagene Fusion mit Alcon aktiv ab. Die berichtenden Personen—Broadwood Partners, Broadwood Capital und Personen einschließlich Neal C. Bradsher—könnten als wirtschaftlich berechtigte Eigentümer von 13.519.491 Aktien von insgesamt 49.354.123 umlaufenden Aktien angesehen werden (ca. 27,4%). Am 15. September 2025 haben sie eine vorläufige Proxystellung und eine GREEN Proxy Card eingereicht, um Stimmrechte zu sammeln, um die Genehmigung des Merger Agreement sowie einen damit verbundenen nicht-bindenden Vergütungs-Vorschlag bei einer am 23. Oktober 2025 geplanten Sondersitzung abzulehnen. Die berichtenden Personen schlossen am 17. September 2025 eine Joint Filing and Solicitation Agreement, um Einreichungen und Proxy-Solicitation zu koordinieren; Broadwood Partners trägt vorab genehmigte Kosten. Die Einreichung erklärt, dass Herr LeBuhn 21.286 Aktien mit persönlichen Mitteln im Wert von ca. 135.888,02 USD gekauft hat und dass kein berichtender Person in den letzten 60 Tagen Transaktionen durchgeführt hat.
تبلغ مجموعة Broadwood عن امتلاكها حصة نسبتها 27.4% في STAAR Surgical (STAA) وتعارض بنشاط الدمج المقترح مع Alcon. قد يُعَدّ الأشخاص المُبلِّغون—Broadwood Partners وBroadwood Capital وأفراد من بينهم Neal C. Bradsher—أصحاب فائدة مفيدة في 13,519,491 سهماً من إجمالي 49,354,123 سهمًا مقيداً بالتداول (حوالي 27.4%). في 15 سبتمبر 2025 قدموا بيان تفويض خام وبطاقة وكالة GREEN للتصويت لجمع وكلاء مناصرةً لرفض موافقة اتفاق الاندماج ومقترح تعويض غير ملزم ذا صلة في اجتماع خاص مقرّر في 23 أكتوبر 2025. وقّع المُبلِّغون اتفاقاً مشتركاً للإيداع والتحصيل بتاريخ 17 سبتمبر 2025 لتنسيق filings وجمع الوكالات؛ سيتحمّل Broadwood Partners النفقات المعتمدة مسبقاً. تبيّن الوثيقة أن السيد ليبوهن اشترى 21,286 سهماً من أمواله الشخصية بما يقرب من 135,888.02 دولار وأنه لم يجرِ أي من المبلغين معاملات خلال آخر 60 يوماً.
Broadwood集团宣布在STAAR Surgical(STAA)持股27.4%,并积极反对与Alcon拟议的合并。 报告人——Broadwood Partners、Broadwood Capital及包括Neal C. Bradsher在内的个人——可能被视为受益所有人,持有49,354,123股在外流通股中的13,519,491股(约27.4%)。2025年9月15日,他们提交了初步的代理声明和GREEN Proxy Card,以征集代理权,在计划于2025年10月23日举行的特别会议上反对通过合并协议及相关的非绑定性薪酬提案。报告人于2025年9月17日签署了联合 filing and Solicitation Agreement,以协调提交文件和代理人招募;Broadwood Partners将承担经预先批准的费用。该文件披露LeBuhn先生以个人资金购入21,286股,金额约为135,888.02美元,且在过去60天内没有任何报告人进行交易。
- Material stake disclosed: Reporting Persons may beneficially own 13,519,491 shares, about 27.4% of outstanding stock.
- Organized coordination: Reporting Persons entered a Joint Filing and Solicitation Agreement dated September 17, 2025 to jointly file and solicit proxies.
- Public proxy action initiated: Preliminary proxy statement and GREEN Proxy Card filed on September 15, 2025 to solicit proxies concerning the Proposed Merger.
- Opposition to Proposed Merger: The Reporting Persons expressly intend to oppose stockholder approval of the Merger Agreement and related Compensation Proposal at the October 23, 2025 special meeting.
- Potential for contested vote: The coordinated solicitation indicates a proxy contest environment that could delay or complicate completion of the Proposed Merger.
Insights
TL;DR: Broadwood controls a material 27.4% and has launched a coordinated proxy solicitation to block the Alcon merger.
Broadwood's reported shared beneficial ownership of 13,519,491 shares (27.4% of outstanding) is a significant position that supports a coordinated campaign to solicit proxies against the Merger Agreement scheduled for a stockholder vote on October 23, 2025. The filing shows formal organization of a group via a Joint Filing and Solicitation Agreement and the use of a GREEN Proxy Card, indicating a public, organized effort to oppose the deal. This level of ownership and the announced solicitation are material to the outcome of the special meeting and to any negotiating leverage between Broadwood and the Issuer or Alcon.
TL;DR: The Reporting Persons formed a joint solicitation group and disclosed intent to oppose merger and compensation proposals at the special meeting.
The Schedule 13D/A discloses formation of a formal group and allocation of responsibilities (expenses borne by Broadwood Partners) via a Joint Filing and Solicitation Agreement dated September 17, 2025. The filing explicitly states the Reporting Persons will solicit proxies to oppose both the Merger Agreement Proposal and the non-binding Compensation Proposal at the October 23, 2025 special meeting. The disclosure of individual purchases (Mr. LeBuhn: 21,286 shares, ~$135,888.02) and the absence of transactions in the past 60 days are noted. These contractual and procedural details are central to proxy contest mechanics and regulatory compliance.
Il gruppo Broadwood segnala una partecipazione del 27,4% in STAAR Surgical (STAA) e si oppone attivamente alla fusione proposta con Alcon. I Reporting Persons—Broadwood Partners, Broadwood Capital e individui tra cui Neal C. Bradsher—potrebbero essere considerati titolari beneficiari di 13.519.491 azioni su un totale di 49.354.123 in circolazione (circa il 27,4%). Il 15 settembre 2025 hanno presentato una bozza preliminare di procura e una GREEN Proxy Card per richiedere deleghe al fine di opporsi all’approvazione dell’Merger Agreement e a una proposta di compensazione non vincolante correlata, in occasione di una riunione speciale prevista per il 23 ottobre 2025. I Reporting Persons hanno stipulato un Joint Filing and Solicitation Agreement il 17 settembre 2025 per coordinare nomine e sollecitazione delle deleghe; Broadwood Partners si farà carico delle spese pre-approvate. Il fascicolo indica che il signor LeBuhn ha acquistato 21.286 azioni per circa 135.888,02 dollari con fondi personali e che nessun Reporting Person ha effettuato operazioni negli ultimi 60 giorni.
El grupo Broadwood informa una participación del 27,4% en STAAR Surgical (STAA) y se opone activamente a la fusión propuesta con Alcon. Las Personas que Informan—Broadwood Partners, Broadwood Capital y particulares, incluido Neal C. Bradsher—podrían considerarse propietarios beneficiarios de 13.519.491 acciones de un total de 49.354.123 en circulación (aproximadamente el 27,4%). El 15 de septiembre de 2025 presentaron una declaración preliminar de poder y una Green Proxy Card para solicitar delegaciones con el fin de oponerse a la aprobación del Acuerdo de Fusión y a una propuesta de compensación no vinculante relacionada, en una reunión especial programada para el 23 de octubre de 2025. Las Personas que Informan firmaron un Acuerdo conjunto de Presentación y Solicitud de poder el 17 de septiembre de 2025 para coordinar presentaciones y la solicitud de poderes; Broadwood Partners asumirá gastos preaprobados. El expediente indica que el señor LeBuhn compró 21.286 acciones por aproximadamente $135.888,02 con fondos personales y que ninguna Persona Informante ha operado en los últimos 60 días.
브로드우드 그룹은 STAAR Surgical(STAA)에 27.4%의 지분을 보유하고 있으며 Alcon과의 제안된 합병에 적극적으로 반대하고 있습니다. 보고인들—Broadwood Partners, Broadwood Capital 및 Neal C. Bradsher를 포함한 개인들—은 발행 주식 총수 49,354,123주 중 13,519,491주를 유익하게 소유할 수 있다고 간주될 수 있습니다(약 27.4%). 2025년 9월 15일 예비 위임장 및 GREEN Proxy Card를 제출하여 2025년 10월 23일로 예정된 특별 주주총회에서 합병계약 승인에 반대하고 관련 비구속적 보상 제안에 반대하기 위한 위임장을 모으려 했습니다. 보고인들은 2025년 9월 17일에 서류 제출 및 위임 모집을 조정하는 공동 제출 및 위임 모집 계약(Joint Filing and Solicitation Agreement)을 체결했습니다; Broadwood Partners는 사전 승인된 비용을 부담할 것입니다. 제출서는 LeBuhn 씨가 개인 자금으로 약 135,888.02달러에 21,286주를 매수했고, 지난 60일 동안 어떤 보고인도 거래를 하지 않았다고 밝힙니다.
Le groupe Broadwood indique une participation de 27,4 % dans STAAR Surgical (STAA) et s’oppose activement à la fusion proposée avec Alcon. Les personnes détenant l’information—Broadwood Partners, Broadwood Capital et des particuliers dont Neal C. Bradsher—pourraient être considérées comme détenant des actions bénéficiaires à hauteur de 13 519 491 sur un total de 49 354 123 actions en circulation (environ 27,4 %). Le 15 septembre 2025, ils ont déposé une déclaration préliminaire et une GREEN Proxy Card pour solliciter des procurations afin de s’opposer à l’approbation du Merger Agreement et à une proposition de rémunération non contraignante associée, lors d’une assemblée spéciale prévue le 23 octobre 2025. Les personnes détenant l’information ont signé un accord conjoint de dépôt et de sollicitation le 17 septembre 2025 pour coordonner les dépôts et la sollicitation de procurations; Broadwood Partners assumera les dépenses préapprouvées. Le dossier révèle que M. LeBuhn a acheté 21 286 actions pour environ 135 888,02 $ avec des fonds personnels et qu’aucune des personnes détenant l’information n’a effectué de transactions au cours des 60 derniers jours.
Die Broadwood-Gruppe meldet eine Beteiligung von 27,4 % an STAAR Surgical (STAA) und lehnt die vorgeschlagene Fusion mit Alcon aktiv ab. Die berichtenden Personen—Broadwood Partners, Broadwood Capital und Personen einschließlich Neal C. Bradsher—könnten als wirtschaftlich berechtigte Eigentümer von 13.519.491 Aktien von insgesamt 49.354.123 umlaufenden Aktien angesehen werden (ca. 27,4%). Am 15. September 2025 haben sie eine vorläufige Proxystellung und eine GREEN Proxy Card eingereicht, um Stimmrechte zu sammeln, um die Genehmigung des Merger Agreement sowie einen damit verbundenen nicht-bindenden Vergütungs-Vorschlag bei einer am 23. Oktober 2025 geplanten Sondersitzung abzulehnen. Die berichtenden Personen schlossen am 17. September 2025 eine Joint Filing and Solicitation Agreement, um Einreichungen und Proxy-Solicitation zu koordinieren; Broadwood Partners trägt vorab genehmigte Kosten. Die Einreichung erklärt, dass Herr LeBuhn 21.286 Aktien mit persönlichen Mitteln im Wert von ca. 135.888,02 USD gekauft hat und dass kein berichtender Person in den letzten 60 Tagen Transaktionen durchgeführt hat.